Arama

EISSN 2148-4279

EJR IS INDEXED IN WEB OF SCIENCE AND PUBMED CENTRAL

European Journal of Rheumatology

PDF

HIGHLY CITED ARTICLES

Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus

Sawalha, Amr H.; Manzi, Susan.

Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg

Crayne, Courtney; Cron, Randy Q.

The emerging role of lung ultrasound in COVID-19 pneumonia

Lepri, Gemma; Orlandi, Martina; Lazzeri, Chiara; Bruni, Cosimo; Hughes, Michael; Bonizzoli, Manuela; Wang, Yukai; Peris, Adriano; Matucci-Cerinic, Marco.

Baricitinib in therapy of COPA syndrome in a 15-year-old girl

Krutzke, Sophia; Rietschel, Christoph; Horneff, Gerd.

New perspectives in the imaging of Raynaud's phenomenon

Herrick, Ariane L.; Dinsdale, Graham; Murray, Andrea.

The contribution of mesenchymal transitions to the pathogenesis of systemic sclerosis

Rosa, Irene; Romano, Eloisa; Fioretto, Bianca Saveria; Manetti, Mirko.

Pediatric Behcet's disease - clinical aspects and current concepts

Yildiz, Mehmet; Koker, Oya; Adrovic, Amra; Sahin, Sezgin; Barut, Kenan; Kasapcopur, Ozgur.

Understanding the cytokine storm during COVID-19: Contribution of preexisting chronic inflammation

Miossec, Pierre.

The impact of COVID-19 on rheumatology clinical practice and university teaching in Sydney, Australia

Cai, Ken; He, Jianna; Wong, Peter K. K.; Manolios, Nicholas.

Characteristics of coexisting localized scleroderma and inflammatory arthritis

Reiff, Daniel; Crayne, Courtney B.; Mannion, Melissa L.; Cron, Randy Q.

All Title Keyword Full Text DOI

Authors

Article Type

Article Category

Year

Search Results

Total of 2 results

Ranking

Release Date Sort Sort Article Type

Subclinical biventricular systolic dysfunction in patients with systemic sclerosis

Şükrü Taylan Şahin, Neslihan Yılmaz, Betül Cengiz, Selen Yurdakul, Yonca Çağatay, Esra Kaya, Saide Aytekin, Şule Yavuz

(Eur J Rheumatol 2019; 6: 89-93) DOI: 10.5152/eurjrheum.2019.18155

Abstract Full Text (PDF) Related Articles

What are the main factors affecting the outcome of tocilizumab therapy in COVID-19-induced cytokine release syndrome?

Cansu Akleylek, Seray Gizem Gür, Ibrahim Halil Sever, Safiye Koçulu Demir, Esin Cevik, Egemen Eken, Zafer Gökkaya, Yonca Çağatay, Neslihan Yılmaz

(Eur J Rheumatol 2022; 9: 126-131) DOI: 10.5152/eurjrheum.2022.21010

Abstract Full Text (PDF) Related Articles